<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body class="page">
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span><a href="/">&larr; Back to Home</a></span>
        <span class="date">2024-12-13</span>
        
        
        
          
        
        
        <span><a href="https://github.com/rainoffallingstar/daily-rss/edit/master/content/post/pubmed-ncbi-nlm-nih-gov-39672641-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241214171553-v-2-18-0-post9-.md">Edit this page &rarr;</a></span>
        
        
      
      </div>
    </nav>

<div class="container">
<article>
<div class="article-meta">

  <div class="categories">
  
  </div>

  <h1><span class="title">Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma</span></h1>

  

  
  

</div>



<main>
<p>Immune checkpoint inhibitors have transformed the future management of classic Hodgkin lymphoma (CHL) in the frontline and salvage settings. Both nivolumab and pembrolizumab have high efficacy in CHL allowing for reduction of chemotherapy and possibly the use of radiotherapy based on short-term follow-up. In this review article, we highlight recent trials enrolling patients with relapse and refractory classic Hodgkin lymphoma receiving monotherapy with PD-1 inhibitors as well as PD-1 &hellip;</p>

<script>
var url = "https://pubmed.ncbi.nlm.nih.gov/39672641/?utm_source=curl\u0026utm_medium=rss\u0026utm_campaign=pubmed-2\u0026utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh\u0026fc=20220923065203\u0026ff=20241214171553\u0026v=2.18.0.post9+e462414";
var strReg = "http|https";
var re = new RegExp(strReg);
setTimeout(function() { if(re.test(url)) {window.location.href = url} }, 10000);
</script>
</main>




<nav class="post-nav">
  <span class="nav-prev"><a href="/post/pubmed-ncbi-nlm-nih-gov-39672636-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241214171553-v-2-18-0-post9-/">&larr; Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024</a></span>
  <span class="nav-next"><a href="/post/pubmed-ncbi-nlm-nih-gov-39672696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241214171558-v-2-18-0-post9-/">ChatGPT vs. surgeons on pancreatic cancer queries: accuracy &amp;amp; empathy evaluated by patients and experts &rarr;</a></span>
</nav>




</article>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

